Screener
Bolt Biotherapeutics, Inc. BOLT Q4 2025 Annual earnings
Reported March 12, 2026 · After market close
Revenue$2.5MBeat by $1.8M
EPS-$3.84Beat by $0.46
Revenue estimate$666.7K
EPS estimate-$4.30
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$68.3K
EPS estimate-$3.89
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bolt Biotherapeutics, Inc. report Q4 2025 earnings?
- Bolt Biotherapeutics, Inc. (BOLT) reported Q4 2025 earnings on March 12, 2026 after market close.
- What were Bolt Biotherapeutics, Inc.'s Q4 2025 revenue and EPS?
- Bolt Biotherapeutics, Inc. reported revenue of $2.5M and eps of $-3.84 for Q4 2025.
- Did Bolt Biotherapeutics, Inc. beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $666.7K by $1.8M. EPS beat the consensus estimate of $-4.30 by $0.46.
- How did Bolt Biotherapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 24900.0% from $10.0K a year earlier and eps grew 49.5% from $-7.60.
- Where can I find Bolt Biotherapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-104102) and the 10-K periodic report (0001193125-26-104121) directly on SEC EDGAR. The filing index links above go to sec.gov.
